These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2390670)

  • 21. The effects of nerve terminal activity on non-quantal release of acetylcholine at the mouse neuromuscular junction.
    Zemková H; Vyskocil F; Edwards C
    J Physiol; 1990 Apr; 423():631-40. PubMed ID: 2388160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing the low-frequency associated nicotinic ACh autoreceptor-mediated depression of ACh release from rat motor nerve terminals.
    Prior C; Singh S
    Br J Pharmacol; 2000 Mar; 129(6):1067-74. PubMed ID: 10725254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciguatoxin enhances quantal transmitter release from frog motor nerve terminals.
    Molgó J; Comella JX; Legrand AM
    Br J Pharmacol; 1990 Apr; 99(4):695-700. PubMed ID: 1972891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladder.
    Somogyi GT; de Groat WC
    J Auton Nerv Syst; 1992 Feb; 37(2):89-97. PubMed ID: 1607601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutual dependence of calcitonin-gene related peptide and acetylcholine release in neuromuscular preparations.
    Kimura I; Okazaki M; Nojima H
    Eur J Pharmacol; 1997 Jul; 330(2-3):123-8. PubMed ID: 9253944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism by tubocurarine and verapamil of the regenerative acetylcholine release from mouse motor nerve.
    Hong SJ; Chang CC
    Eur J Pharmacol; 1989 Mar; 162(1):11-7. PubMed ID: 2721560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A regenerating release of acetylcholine from mouse motor nerve terminals treated with anticholinesterase agents.
    Chang CC; Hong SJ
    Neurosci Lett; 1986 Aug; 69(2):203-7. PubMed ID: 3763048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement by carbachol of transmitter release from motor nerve terminals.
    Miyamoto MD; Volle RL
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1489-92. PubMed ID: 4364541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.
    Plomp JJ; van Kempen GT; Molenaar PC
    J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):125-36. PubMed ID: 7965828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hexamethonium- and methyllycaconitine-induced changes in acetylcholine release from rat motor nerve terminals.
    Tian L; Prior C; Dempster J; Marshall IG
    Br J Pharmacol; 1997 Nov; 122(6):1025-34. PubMed ID: 9401765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptozocin-diabetes modifies acetylcholine release from mouse phrenic nerve terminal and presynaptic sensitivity to succinylcholine.
    Kimura I; Okazaki M; Kimura M
    Jpn J Pharmacol; 1993 May; 62(1):35-41. PubMed ID: 8341027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of atropine and oxotremorine on acetylcholine release in rat phrenic nerve-diaphragm preparations.
    Abbs ET; Joseph DN
    Br J Pharmacol; 1981 Jun; 73(2):481-3. PubMed ID: 7236997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by neosurugatoxin and omega-conotoxin of acetylcholine release and muscle and neuronal nicotinic receptors in mouse neuromuscular junction.
    Hong SJ; Tsuji K; Chang CC
    Neuroscience; 1992; 48(3):727-35. PubMed ID: 1318519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postsynaptic nicotinic ACh receptor-operated Ca2+ transients with neostigmine in phrenic nerve-diaphragm muscles of mice.
    Kimura I; Kondoh T; Kimura M
    Brain Res; 1990 Jan; 507(2):309-11. PubMed ID: 2337770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscarinic M1 acetylcholine receptors regulate the non-quantal release of acetylcholine in the rat neuromuscular junction via NO-dependent mechanism.
    Malomouzh AI; Mukhtarov MR; Nikolsky EE; Vyskočil F
    J Neurochem; 2007 Sep; 102(6):2110-2117. PubMed ID: 17561934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ryanodine facilitates calcium-dependent release of transmitter at mouse neuromuscular junctions.
    Nishimura M; Tsubaki K; Yagasaki O; Ito K
    Br J Pharmacol; 1990 May; 100(1):114-8. PubMed ID: 1973623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction between hexamethonium and tubocurarine on the rat neuromuscular junction.
    Rang HP; Rylett RJ
    Br J Pharmacol; 1984 Mar; 81(3):519-31. PubMed ID: 6141831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A selective inhibitor of cAMP-specific phosphodiesterase, Ro 20-1724, has no effect on the quantal release of acetylcholine from the mouse phrenic nerve.
    Chiou LC; Chang CC
    J Pharm Pharmacol; 1988 Feb; 40(2):148-9. PubMed ID: 2897454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Bay K 8644 on spontaneous and evoked transmitter release at the mouse neuromuscular junction.
    Pancrazio JJ; Viglione MP; Kim YI
    Neuroscience; 1989; 30(1):215-21. PubMed ID: 2473411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allosteric interaction of the anticholinergic drug [N-(4-phenyl)-phenacyl-l-hyoscyamine] (Phenthonium) with nicotinic receptors of post-ganglionic sympathetic neurons of the rat vas deferens.
    Munhoz E; De Lima TC; Souccar C; Lapa AJ; Lima-Landman MT
    Eur J Pharmacol; 2009 Aug; 616(1-3):229-35. PubMed ID: 19540221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.